Several studies have recently reported on the role of DC-SIGN promoter variants in the susceptibility to or pathogenesis of various infectious diseases, such as dengue fever [25, 28], tuberculosis [13, 14, 29, 30], Acquired Immune Deficiency Syndrome (AIDS) [19, 31–33], celiac disease [34]. This evidence concerns the gene CD209 and infectious disease.